Researcher
Catherine Verfaillie
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Stem Cell and Developmental Biology (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Infrastructure
1 - 1 of 1
- Platform for Next Generation Screening in Quantitative Biology & Drug Discovery (Consortium coordinator)
Projects
1 - 10 of 95
- Business development of a drug screening Spin-off company based on 2D & 3D human iPSC-derived liver cell models for NASH & (i)DILI.From1 Aug 2021 → 31 Jan 2022Funding: IOF - mandates
- RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3RsFrom1 Jun 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Robotized Human Liver-Mimic 3D Model Platform for Efficient NAFLD and DILI Compound ScreeningFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- Advanced 3D Complex Tissues BioAssembly Platform for Precision Disease Modeling, Drug Discovery and Regenerative Medicine (3D-BioBOT)From1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- In vitro functional formation of liver sinusoidal endothelial cells in 3D culture system.From1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- iPSC-based parenchymal and sinusoidal liver cell mimics for DILI and NAFLD studies (iPSC-LiMic)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- Drug discovery for Parkinson’s disease using a translational screening platformFrom1 Oct 2020 → 31 Mar 2024Funding: IOF - technology validation in lab
- OrganID: Organ-derived complex 2D/3D cultures in human diseaseFrom1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- Proof of concept: immunotherapy in glioblastoma multiforme.From21 Sep 2020 → TodayFunding: FWO fellowships
- 3D-PADchip: Engineering 3D Perfusable human "Alzheimer's Disease (AD)-On-Chip ModelFrom28 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
311 - 320 of 375
- Hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a novel non-viral paradigm for coaxed differentiation(2010)
Authors: Marinee Chuah, Eyayu Belay, Janka Matrai, Abel Acosta Sanchez, L Ma, M Quattrocelli, L Mates, P Sancho-Bru, M Geraerts, B Yan, et al.
Pages: 1174 - 1174 - Mouse MAPC-mediated immunomodulation: Cell-line dependent variation(2010)
Authors: Ariane Luyckx, Lien De Somer, Mark Waer, Catherine Verfaillie, Stefaan Van Gool, An Billiau
Pages: 1 - 2 - Hepatic stem cells(2010)
Authors: Catherine Verfaillie
Pages: 167 - 79 - A scalable approach for discovering conserved active subnetworks across species(2010)
Authors: Catherine Verfaillie
- Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow(2010)
Authors: Martine Geraerts, Yonsil Park, Catherine Verfaillie
Pages: 55 - 78 - Immune modulatory capacities of human multipotent adult progenitor cells on natural killer cell proliferation, cytokine production, and cytotoxicity(2010)
Authors: Sandra Jacobs, J Pinxteren, W Van't Hof, R Deans, Catherine Verfaillie, S Van Gool
Pages: 929 - 929 - Differentiation of rat multipotent adult progenitor cells to functional hepatocyte-like cells by mimicking embryonic liver development(2010)
Authors: Philip Roelandt, Catherine Verfaillie
Pages: 1324 - 1336 - Directed differentiation of mouse cochlear neural progenitors in vitro (Retraction of vol 296, pg C441, 2009)(2009)
Authors: J Lin, L Feng, Y Hamajima, M Komori, TC Burns, S Fukudome, J Anderson, D Wang, Catherine Verfaillie, WC Low
Pages: C1596 - C1596 - Differentiation of cochlear neural progenitors with SV40 in vitro(2009)
Authors: L Feng, Y Hamajima, M Komori, J Anderson, D Wang, TC Burns, Catherine Verfaillie, WC Low, J Lin
Pages: 11 - 22 - Fibrinolysis-independent role of plasmin and its activators in the hematopoietic recovery after myeloablation(2009)
Authors: Marc Tjwa, Lieve Moons, Stéphane Plaisance, Mieke Dewerchin, Catherine Verfaillie, Peter Carmeliet
Pages: 4587 - 4595
Patents
1 - 10 of 10
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Hydrogels for cell culture (Inventor)
- Nek6 inhibition to treat als and ftd (Inventor)
- Spheroidal self-assembled peptide hydrogels comprising cells (Inventor)
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Cell culture media for differentiation of stem cells into hepatocytes (Inventor)
- Methods for identifying activators and suppressors (Inventor)
- Stem cell aggregates and methods for making and using (Inventor)
- Cell therapy for myelodysplastic syndromes (Inventor)
- Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells (Inventor)